Wesche Holger
Chief Scientific Officer at Harpoon Therapeutics, Inc.
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Jul 1, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Harpoon Therapeutics, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Harpoon Therapeutics, Inc.Plan not statedApr 28, 2020 2020
Sold 1,250 shares at $14.05 ($18k)
Wesche Holger, Chief Scientific Officer
Sold 2.3% of holdings ($758k position)52,669 shares leftFiling
- 2 Form 4 sale Harpoon Therapeutics, Inc.Plan not statedMay 11, 2020 +13 days
Sold 7,350 shares at $14.10 ($104k)
Wesche Holger, Chief Scientific Officer
Sold 12.2% of holdings ($847k position)52,669 shares leftFiling
- 3 Form 4 sale Harpoon Therapeutics, Inc.Plan not statedMay 12, 2020 +1 day
Sold 1,400 shares at $14.09 ($20k)
Wesche Holger, Chief Scientific Officer
Sold 2.6% of holdings ($762k position)52,669 shares left0.2x usual sizeFiling
- 4 Form 4 sale Harpoon Therapeutics, Inc.Plan not statedJul 1, 2020 +50 days
Sold 10,000 shares at $16.20 ($162k)
Wesche Holger, Chief Scientific Officer
Sold 16% of holdings ($1M position)52,669 shares left2.3x usual sizeFiling
- 5 Form 4 sale Harpoon Therapeutics, Inc.Plan not statedOct 1, 2020 +92 days
Sold 10,000 shares at $16.27 ($163k)
Wesche Holger, Chief Scientific Officer
Sold 16% of holdings ($1M position)52,669 shares left1.4x usual sizeFiling
- 6 Form 4 sale Harpoon Therapeutics, Inc.Plan not statedJan 4, 2021 +95 days
Sold 10,000 shares at $18.38 ($184k)
Wesche Holger, Chief Scientific Officer
Sold 15.9% of holdings ($1.2M position)52,852 shares left1.2x usual sizeFiling
- 7 Form 4 sale Harpoon Therapeutics, Inc.Plan not statedApr 1, 2021 +87 days
Sold 10,000 shares at $20.45 ($204k)
Wesche Holger, Chief Scientific Officer
Sold 15.9% of holdings ($1.3M position)52,852 shares left1x usual sizeFiling
- 8 Form 4 sale Harpoon Therapeutics, Inc.Plan not statedJul 1, 2021 +91 days
Sold 10,000 shares at $14.00 ($140k)
Wesche Holger, Chief Scientific Officer
Sold 15.9% of holdings ($880k position)52,852 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | Jul 6, 2021 | Harpoon Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $140k | 15.9% | Plan not stated | SEC |
| Apr 1, 2021 | Apr 5, 2021 | Harpoon Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $204k | 15.9% | Plan not stated | SEC |
| Jan 4, 2021 | Jan 6, 2021 | Harpoon Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $184k | 15.9% | Plan not stated | SEC |
| Oct 1, 2020 | Oct 5, 2020 | Harpoon Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $163k | 16.0% | Plan not stated | SEC |
| Jul 1, 2020 | Jul 2, 2020 | Harpoon Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $162k | 16.0% | Plan not stated | SEC |
| May 12, 2020 | May 13, 2020 | Harpoon Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 1,400 | $20k | 2.6% | Plan not stated | SEC |
| May 11, 2020 | May 11, 2020 | Harpoon Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 7,350 | $104k | 12.2% | Plan not stated | SEC |
| Apr 28, 2020 | Apr 30, 2020 | Harpoon Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 1,250 | $18k | 2.3% | Plan not stated | SEC |
| Jan 2, 2020 | Jan 6, 2020 | Harpoon Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $144k | 16.0% | Plan not stated | SEC |